Abstract

Genipin (GN) is a natural molecule extracted from the fruit of Gardenia jasminoides Ellis according to modern microbiological processes. Genipin is considered as a favorable cross-linking agent due to its low cytotoxicity compared to widely used cross-linkers; it cross-links compounds with primary amine groups such as proteins, collagen, and chitosan. Chitosan is a biocompatible polymer that is currently studied in bone tissue engineering for its capacity to promote growth and mineral-rich matrix deposition by osteoblasts in culture. In this work, two genipin cross-linked chitosan scaffolds for bone repair and regeneration were prepared with different GN concentrations, and their chemical, physical, and biological properties were explored. Scanning electron microscopy and mechanical tests revealed that nonremarkable changes in morphology, porosity, and mechanical strength of scaffolds are induced by increasing the cross-linking degree. Also, the degradation rate was shown to decrease while increasing the cross-linking degree, with the high cross-linking density of the scaffold disabling the hydrolysis activity. Finally, basic biocompatibility was investigated in vitro, by evaluating proliferation of two human-derived cell lines, namely, the MG63 (human immortalized osteosarcoma) and the hMSCs (human mesenchymal stem cells), as suitable cell models for bone tissue engineering applications of biomaterials.

Highlights

  • The occurrence of bone defects with critical size impairing regeneration and self-repair is a key problem in orthopaedic surgery [1]

  • Two genipin cross-linked chitosan scaffolds for bone repair and regeneration were prepared with different GN concentrations, and their chemical, physical, and biological properties were explored

  • Lysozyme for degradation assays was purchased from Sigma-Aldrich (CAS 12650-88-3), and phosphate-buffered saline (PBS) solution was from Fluka

Read more

Summary

Introduction

The occurrence of bone defects with critical size impairing regeneration and self-repair is a key problem in orthopaedic surgery [1]. The ideal solution is the autologous bone graft, which is the gold standard in clinical practice, because it possesses all the characteristics for bone growth: osteoconductivity, osteoinductivity, and osteogenicity [1,2,3]. It is a safe solution for compatibility and for the absence of immunogenicity, autograft is affected by problems such as donor site morbidity and limited supply [4]. Bone allografts and xenografts are alternatives, but they are expensive and imply the risk of disease transmission and adverse host immune reaction

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call